Q4 and FY consensus estimates

Estimates for Q4 and FY 2020/21 based on median.

   Q4 2020/21        FY 2020/21 
DKKm LowConsensusHigh LowConsensusHigh
         
Revenue 

1,027

1,027 1,028 4,0144,0144,014
Gross profit 

515

612640 

2,408

2,5052,533
Gross margin 

50.2%

59.6%62.3% 

60.0%

62.4%63.1%
EBIT before special items 

5

1623 341356360
EBIT margin before special items 

0.5%

1.6%2.3% 8.5%8.8%9.0%
Net profit 

-33

-1314 215236264
Net profit margin 

-3.2%

-1.2%1.4% 5.4%5.9%6.6%
         
Endoscopes sold (units) 389,596390,000391,000 

1,524,596

1,525,0001,526,000
Organic growth 17.7%18.0%18.1% 

16.0%

16.2%16.4%

29 October 2021, based on estimates from 9 analysts.

keyboard_arrow_up